Multilex drug terminology offers comprehensive medication coverage including all POM, P and GSL licensed primary and secondary care products and packs, many unlicensed products, licensed herbal products and homoeopathics.
Medical devices, nutritional supplements and ingredients for extemporaneous preparations are added in line with regional drug tariff publications. Additional products are considered for addition on request from our customers and users.
Medication concepts to support generic prescribing are available while the products that should be prescribed ‘by brand’ are flagged as such. A pick list to include the marketed brands and manufactured generic products and packs, together with their flavour, colour and ‘sugar free’ status as appropriate, is available to support dispensing doctors and pharmacists.
Multilex Orderable Medications have been developed specifically for secondary care to support dose based prescribing, allowing users to prescribe unambiguously with the minimum number of steps using Drug Name and Route and, where applicable, Formulation and Strength, which can be coupled directly with Multilex Dose sentences to generate an Order Sentence. Appropriate solutions for administration and dispensing are also provided, further streamlining the medications management process.
All medication pick lists can be navigated using search terms or browsed by classification. Results can be filtered by market status, product type (e.g. drug or appliance), medication type (e.g. homoeopathic) or healthcare profession (e.g. nurse or dentist). The user can be made aware of any products that are under Commission of Human Medicines (CHM) black triangle surveillance or carry an NPSA high risk warning e.g. oral methotrexate once weekly dosing. Drug names can be displayed using TALLMAN lettering in order to help the user distinguish between similarly named products.
A number of safety features are available including; products are identified by the National Patient Safety Agency (NPSA) as high risk; black triangle products are identified (Commission on Human Medicines (CHM) surveillance) and use of TALLMAN lettering to help to reduce selection confusion by visually distinguishing between products that have similar names.
Multilex drug terminology is linked to a wide range of standard drug terminologies including Read 2, Clinical Terms Version 3, the NHS Dictionary of Medicines and Devices (dm+d) and regional drug terminologies such as the Irish Pharmaceutical Union codes, the eVADIS codes within the GPASS system in Scotland and the Medusa drug codes used in pharmacy systems in Wales as well as certain proprietary drug terminologies. The Multilex drug terminology is also linked PIP codes to support stock control.